NCT02572817: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02572817 |
|---|---|
| Title | A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 30, 2015 |
| Completion date | April 26, 2018 |
| Required reporting date | April 26, 2019, midnight |
| Actual reporting date | April 24, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |